Table 2. Use of prescription medications over the past 12 months by stroke characteristics.
| Prescription medication | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Stroke characteristics | Lipid lowering agent A | Antihypertensive B | Anticoagulant or antiplatelet C | Total | ||||||
| Yes | No | Yes | No | Yes | No | Yes | No | |||
| (n = 116) | (n = 460) | (n = 208) | (n = 368) | (n = 272) | (n = 304) | (n = 247) | (n = 329) | |||
| % | % | % | % | % | % | % | % | |||
| Years since | <10 years | (n = 319) | 63.8 | 53.3 | 55.7 | 55.2 | 59.6 | 51.6 | 57.5 | 52.6 |
| diagnosis | ≥10 years | (n = 257) | 36.2 | 46.7 | 44.3 | 44.8 | 40.4 | 48.4 | 42.5 | 47.4 |
| p-value | 0.041 | 0.888 | 0.056 | 0.250 | ||||||
| Degree of | 0–2 points | (n = 374) | 67.2 | 64.4 | 63.0 | 66.0 | 68.0 | 62.2 | 66.3 | 63.2 |
| disability 1 | 3–5 points | (n = 202) | 32.8 | 35.6 | 37.0 | 34.0 | 32.0 | 37.8 | 33.7 | 36.8 |
| p-value | 0.559 | 0.461 | 0.142 | 0.440 | ||||||
| Level of | ≤10 points | (n = 516) | 93.1 | 88.7 | 90.9 | 88.9 | 90.1 | 89.1 | 90.6 | 88.3 |
| fatigue 2 | >10 points | (n = 60) | 6.9 | 11.3 | 9.1 | 11.1 | 9.9 | 10.9 | 9.4 | 11.7 |
| p-value | 0.165 | 0.449 | 0.716 | 0.367 | ||||||
A lipid lowering agent such as Atorvastatin, Caduet, Lipitor, and Rosuvastatin.
B antihypertensive such as Atacand, Avapro, Coversyl, and Micardis.
C anticoagulant or antiplatelet such as Cartia, Plavix, Pradaxa, and Warfarin.
1 modified Rankin Scale (mRS) (0 = no disability and 5 = severe disability)
2 Modified Fatigue Impact Scale– 5-item version (MFIS-5)